Betacellulin is downregulated in plaque psoriasis and may reflect disease severity

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1030-e1033. doi: 10.1111/jdv.18433. Epub 2022 Jul 22.

Authors

G Peng^{1

2}, S Tsukamoto^{1

2}, R Kishi^{3

4}, M Tominaga³, K Takamori^{3

4}, K Okumura², H Ogawa², S Ikeda^{1

2}, F Niyonsaba^{2

5}

Affiliations

¹ Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
² Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
³ Juntendo Itch Research Center (JIRC), Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan.
⁴ Department of Dermatology, Juntendo University Urayasu Hospital, Chiba, Japan.
⁵ Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan.

PMID: 35841300
DOI: 10.1111/jdv.18433

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Betacellulin
Humans
Patient Acuity
Psoriasis* / complications
Severity of Illness Index

Substances

Betacellulin

Grants and funding

NEA21-ERG159/National Eczema Association